DA SQUARED PHARMA CONSULTING LTD

Company number 09190133 ·

Active

Net assets, total assets & total liabilities 2016 – 2025

  • Total assets
  • Net assets
  • Total liabilities
-£100k £0 £100k £200k £300k £400k £500k 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Total assets 2016: £244,057 Total assets 2017: £273,852 Total assets 2018: £386,960 Total assets 2019: £434,275 Total assets 2020: £428,062 Total assets 2021: £475,103 Total assets 2022: £407,116 Total assets 2023: £420,424 Total assets 2024: £354,033 Total assets 2025: £266,263 Total assets Net assets 2016: £207,042 Net assets 2017: £245,769 Net assets 2018: £349,728 Net assets 2019: £402,054 Net assets 2020: £406,552 Net assets 2021: £451,701 Net assets 2022: £404,350 Net assets 2023: £412,543 Net assets 2024: £351,052 Net assets 2025: £262,764 Net assets Total liabilities 2016: -£35,604 Total liabilities 2017: -£27,188 Total liabilities 2018: -£36,442 Total liabilities 2019: -£31,146 Total liabilities 2020: -£20,670 Total liabilities 2021: -£22,602 Total liabilities 2022: -£1,926 Total liabilities 2023: -£7,006 Total liabilities 2024: -£2,081 Total liabilities 2025: -£2,484 Total liabilities

Figures extracted from filed accounts. Hover a point for the exact value.

Employees 2024 – 2025

0 0 0 0 1 1 1 1 2 2024 2025 2024: 2 2025: 2

Average employees, from filed accounts. Hover a point for the exact figure.

Balance sheet by year 11 years

Latest accounts (2025-08-31): Audit exempt (accountant's report).

Year ending Total assets Total liabilities Net assets Cash Turnover Profit Employees
2025-08-31 £266,263 -£2,484 £262,764 2
2024-08-31 £354,033 -£2,081 £351,052 2
2023-08-31 £420,424 -£7,006 £412,543
2022-08-31 £407,116 -£1,926 £404,350
2021-08-31 £475,103 -£22,602 £451,701
2020-08-31 £428,062 -£20,670 £406,552
2019-08-31 £434,275 -£31,146 £402,054
2018-08-31 £386,960 -£36,442 £349,728
2017-08-31 £273,852 -£27,188 £245,769
2016-08-31 £244,057 -£35,604 £207,042
2015-08-31 £164,191 -£43,336 £120,522 £133,630

Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.